Skip to main content
. 2023 Oct 20;42(11):1241–1251. doi: 10.1200/JCO.23.01891

TABLE A5.

Treatment Intensity and Compliance of Pemetrexed Plus Carboplatin or Cisplatin Arm

Category Induction Phase
No. Mean SD Median Min Max
Pemetrexed
 No. of cycles 74 3.80 0.76 4.00 2.00 6.00
 Relative dose intensity, % 74 97.28 8.15 99.62 52.55 108.89
 Dose reduction 3
 Temporally interruption 0
Cisplatin
 No. of cycles 8 3.50 0.76 4.00 2.00 4.00
 Relative dose intensity, % 8 79.43 22.43 83.68 40.99 101.35
 Dose reduction 2
 Temporally interruption 1
Carboplatin
 No. of cycles 66 3.80 0.77 4.00 2.00 6.00
 Actual dose intensity, mg/week 66 190.60 48.83 187.57 94.04 296.67
 Dose reduction 13
 Temporally interruption 0
Maintenance Phase
Category No. Mean SD Median Min Max
Pemetrexed
 No. of cycles 58 12.91 8.49 10.00 5.00 43.00
 Relative dose intensity, % 58 96.17 10.00 99.06 56.68 121.73
 Dose reduction 5
 Temporally interruption 0

NOTE. Two patients received six cycles of induction pemetrexed/carboplatin.

Abbreviation: SD, standard deviation.